MARFIN CAPITAL S.A. subsidiary of MARFIN FINANCIAL GROUP acquired today 49% of the shares of the Listed Company YGEIA in the context of the Investment Banking activity of the Group. Marfin's intention, in cooperation with Mrs. I. Arvaniti who maintains the control of 23,8% of the shares of YGEIA, is the reorganization of the Company, the partnership with the doctors which constitute its "back bone" and the extension of its operations through strategic moves in the context of the consolidation which is necessary due in the health sector.

The Vice Chairman of Marfin Financial Group, Mr. Andreas Vgenopoulos issued the following statement: "We extend our gratitude to Mrs. I. Arvaniti for her trust, which enabled us to attempt, with her cooperation and through the appropriate restructuring and strategic actions, to reveal the real value of YGEIA for the benefit of its shareholders, its doctors and personnel but also of its clients".

The acquisition of 49% of YGEIA was effected at the price of Euro 2,56 per share without the use of any funds from the recent share capital increase of Marfin Financial Group which will be used for the expansion of the group in the banking sector. Marfin Financial Group?s Management estimates that this deal will have a positive contribution to the company's profits for 2006 by between Euro 0,08 and Euro 0,20 per share, depending on the developments.